Today, more than 1.6 million new malware signatures are identified each month. And more organizations are falling prey to "zero-day" attacks - malware for which an anti-virus signature does not exist. It’s no surprise that roughly half of the organizations surveyed in a 2010 Ponemon Institute study reported an increase in their IT operating expenses - a main driver of that cost increase was malware. Traditional anti-virus simply can't keep up in the malware arms race and relying on it as your primary defense will prove costly. In this webcast, Paul Henry, security and forensics expert, and Chris Merritt, Director of Solution Marketing with Lumension, will examine: * The true cost of anti-virus in terms of PC performance, network bandwidth, IT helpdesk costs, prevention of malware and more * Why application whitelisting is a better approach to defend against rising targeted attacks * How application whitelisting has evolved to provide a new level of intelligence that delivers more effective security and necessary flexibility to improve productivity - in even rapidly changing endpoint environments